News | May 27, 2009

Single High-Dose Radiotherapy Effective for Relieving Vertebral Bone Metastases Pain

May 27, 2009 – A single high dose of radiotherapy is as effective in relieving the pain from vertebral bone metastases as 10 smaller treatments according to new research from the Radiation Therapy Oncology Group (RTOG) that will be presented at the American Society of Clinical Oncology Annual Meeting in Orlando on May 31, 2009. RTOG, an NCI-funded national clinical trials group, is a clinical research component of the American College of Radiology (ACR).

RTOG researchers previously reported that breast and prostate cancer patients with painful bone metastases who received a single radiotherapy treatment of 8 Gy had the same pain relief and narcotic use three months after treatment as patients who received 10 radiotherapy treatments each consisting of 2 Gy for a total of 30 Gy. Researchers also found that patients who received the 8 Gy regimen reported in fewer side effects, although those patients did have to be retreated more often than patients who received the higher dose.

In order to evaluate the effectiveness of short course radiotherapy in patients with painful vertebral bone metastases the RTOG investigators examined a 235 patient subset of the 909 patients entered on the original study, RTOG 9714. The RTOG researchers found the short course to be equally effective as the longer course (8 Gy vs. 30 Gy) showing no statistically significant difference in pain relief [70 percent vs. 62 percent, p=0.59] or narcotic use [27 percent vs. 24 percent, p=0.76] at 3 months.

“It is exciting to confirm that we can provide the same amount of pain relief for patients suffering with vertebral bone metastases with only one visit to their radiation oncologist as we have been providing with 10 visits,” said David D Howell, M.D., the lead author of the analysis from the University of Michigan School of Medicine in Ann Arbor. “With fewer side-effects and comparable pain relief, the single dose treatment is very much appreciated, especially for patients who have already completed one or more courses of treatment for their primary disease.”

For more information: www.acr.org

Related Content

Surging Demand for Image-guided, Stereotactic Radiation Therapy Driving Fiducial Marker Growth
News | Radiation Therapy | August 22, 2019
As fiducial markers gain traction in parallel to rising incidences of various cancer affecting lung, prostate, abdomen...
Videos | Treatment Planning | August 21, 2019
This is an example of the Mirada DLCExpert deep learning software that automatically identifies organs, segments and
First Cancer Patient Treated With Accuray Radixact System With Synchrony Motion Tracking
News | Image Guided Radiation Therapy (IGRT) | August 21, 2019
Physicians at the Froedtert & the Medical College of Wisconsin (MCW) Clinical Cancer Center in Milwaukee have...
Videos | Patient Positioning Radiation Therapy | August 21, 2019
This is a quick demonstration of the Varian Identify image-guided patient positioning system at the...
Videos | Treatment Planning | August 21, 2019
This is a lung cancer tumor radiotherapy...
Videos | Computed Tomography (CT) | August 21, 2019
This is a quick walk around of a mobile 32-slice...
First GammaTile Therapy Case Completed in Arizona
News | Radiation Therapy | August 19, 2019
HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy, a...
Drug Accelerates Blood System's Recovery After Radiation, Chemotherapy

Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications

News | Radiation Therapy | August 16, 2019
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem...